The PAF antagonist activity of a series of enantiomeric dihydropyridin
es is described. In the first example, 1, the PAF antagonist activity
and calcium channel blocking activity reside in opposite enantiomers.
Subsequent examples also display enantioselectivity and the SAR of the
series is described.